This is a table of type bigram and their frequencies. Use it to search & browse the list to learn more about your study carrel.
bigram | frequency |
---|---|
gene expression | 2341 |
gene therapy | 781 |
cell lines | 695 |
gene transfer | 575 |
amino acid | 573 |
immune response | 536 |
stem cells | 523 |
cell line | 437 |
reference genes | 432 |
breast cancer | 393 |
gene delivery | 376 |
prostate cancer | 358 |
differentially expressed | 358 |
growth factor | 355 |
immune responses | 325 |
cancer cells | 323 |
mammalian cells | 311 |
expression levels | 307 |
amino acids | 300 |
cell types | 300 |
class i | 287 |
cell cycle | 287 |
present study | 285 |
additional file | 281 |
epithelial cells | 279 |
human genome | 276 |
respiratory syndrome | 275 |
clinical trials | 261 |
expressed genes | 251 |
expression profiles | 250 |
stem cell | 245 |
immune system | 244 |
innate immune | 242 |
oxidative stress | 240 |
cell proliferation | 240 |
transcription factor | 239 |
important role | 231 |
genes involved | 228 |
type i | 226 |
escherichia coli | 225 |
control group | 224 |
influenza virus | 219 |
cell culture | 218 |
cell death | 217 |
protein expression | 215 |
virus infection | 215 |
mg kg | 213 |
tumor cells | 210 |
leydig cells | 206 |
cell surface | 204 |
acute respiratory | 201 |
transcription factors | 198 |
cord uid | 194 |
doc id | 194 |
rna viruses | 193 |
nucleic acid | 185 |
plasma membrane | 182 |
time pcr | 181 |
lung injury | 178 |
sertoli cells | 176 |
dna methylation | 175 |
reference gene | 174 |
bone marrow | 174 |
expression level | 173 |
performed using | 173 |
plasmid dna | 172 |
lung cancer | 171 |
time points | 170 |
viral infection | 170 |
host cell | 170 |
mediated gene | 170 |
target genes | 169 |
may also | 169 |
candidate genes | 169 |
differential expression | 166 |
germ cell | 166 |
wild type | 165 |
rna interference | 165 |
expression data | 162 |
cell growth | 161 |
viral vectors | 160 |
total rna | 158 |
fold change | 157 |
seminiferous tubules | 156 |
infectious diseases | 156 |
expression patterns | 156 |
smooth muscle | 154 |
endothelial cells | 153 |
cancer cell | 153 |
mesenchymal stem | 153 |
overlapping genes | 152 |
large number | 151 |
two different | 151 |
dna damage | 150 |
mrna expression | 149 |
binding protein | 147 |
statistically significant | 147 |
protein kinase | 146 |
codon usage | 146 |
expression profiling | 145 |
nervous system | 145 |
signaling pathway | 144 |
widely used | 144 |
related genes | 143 |
severe acute | 142 |
signal transduction | 142 |
cell type | 142 |
cystic fibrosis | 142 |
molecular biology | 140 |
results suggest | 139 |
expression analysis | 139 |
cell receptor | 137 |
genomic dna | 137 |
sertoli cell | 137 |
gene ontology | 136 |
like receptor | 136 |
significantly higher | 136 |
genome sequence | 136 |
mast cells | 136 |
wide range | 135 |
vaccinia virus | 135 |
peripheral blood | 134 |
transgene expression | 134 |
genes encoding | 134 |
i i | 133 |
antibiotic resistance | 132 |
western blot | 131 |
human genes | 131 |
mhc class | 131 |
porcine reproductive | 130 |
closely related | 129 |
inflammatory response | 129 |
molecular mechanisms | 129 |
commonly used | 128 |
leydig cell | 128 |
open reading | 127 |
transfection efficiency | 127 |
stranded rna | 126 |
resistance genes | 126 |
dendritic cells | 125 |
gene silencing | 125 |
animal models | 125 |
mouse model | 125 |
data sets | 123 |
target gene | 123 |
analysis revealed | 123 |
molecular weight | 123 |
dna vaccines | 122 |
microarray data | 121 |
previous studies | 120 |
immunodeficiency virus | 120 |
signaling pathways | 118 |
chain reaction | 118 |
whole genome | 118 |
virus type | 117 |
spinal cord | 117 |
infected cells | 117 |
innate immunity | 117 |
polymerase chain | 116 |
nucleic acids | 115 |
sequence analysis | 115 |
dna vaccine | 115 |
reading frame | 114 |
time point | 114 |
blood samples | 114 |
syndrome virus | 114 |
genes associated | 113 |
acid sequence | 113 |
results indicate | 112 |
previously described | 112 |
results showed | 112 |
lentiviral vector | 111 |
ambiguous characters | 111 |
supplementary table | 111 |
go terms | 110 |
transgenic mice | 110 |
significant difference | 110 |
expression profile | 110 |
side effects | 109 |
mass spectrometry | 109 |
monoclonal antibodies | 108 |
flow cytometry | 108 |
significant differences | 107 |
data set | 107 |
regulated genes | 107 |
viral replication | 107 |
virus replication | 106 |
germ cells | 105 |
human disease | 105 |
viral infections | 105 |
drug delivery | 105 |
coding genes | 105 |
gene family | 104 |
positive selection | 104 |
nitric oxide | 104 |
united states | 104 |
microarray analysis | 104 |
ng ml | 104 |
biological processes | 103 |
associated genes | 103 |
phase i | 103 |
cell viability | 102 |
gel electrophoresis | 102 |
high levels | 102 |
cancer therapy | 101 |
prrsv infection | 101 |
taken together | 101 |
rete testis | 101 |
reporter gene | 100 |
data analysis | 99 |
central nervous | 99 |
binding sites | 99 |
type ii | 98 |
reactive oxygen | 98 |
endoplasmic reticulum | 98 |
recombinant protein | 98 |
muscle cells | 98 |
dependent manner | 97 |
monoclonal antibody | 96 |
reverse transcription | 95 |
protein synthesis | 95 |
recent years | 95 |
gene encoding | 95 |
three different | 95 |
tumor suppressor | 94 |
genome size | 94 |
host response | 94 |
phylogenetic analysis | 94 |
cell activation | 94 |
least one | 94 |
blot analysis | 93 |
dna sequences | 93 |
oxygen species | 93 |
defi ciency | 93 |
genes identified | 92 |
single nucleotide | 92 |
generation sequencing | 92 |
shannon entropy | 92 |
gene products | 92 |
human immunodeficiency | 92 |
recombinant proteins | 91 |
next generation | 91 |
dna sequence | 91 |
rhesus macaque | 91 |
reverse transcriptase | 91 |
fusion protein | 90 |
significantly increased | 90 |
reading frames | 90 |
delivery systems | 90 |
highly expressed | 89 |
herpes simplex | 89 |
stably expressed | 89 |
highly conserved | 89 |
gene regulation | 89 |
also found | 88 |
fi rst | 88 |
different types | 88 |
genetic material | 88 |
analysis using | 88 |
reproductive tract | 88 |
also known | 87 |
data suggest | 87 |
first time | 87 |
quantitative real | 86 |
necrosis factor | 86 |
determined using | 86 |
cell adhesion | 86 |
human cells | 86 |
receptor gene | 86 |
factor receptor | 86 |
seq data | 86 |
lentiviral vectors | 85 |
saccharomyces cerevisiae | 85 |
viral genome | 84 |
enrichment analysis | 84 |
target cells | 84 |
ex vivo | 84 |
vascular endothelial | 83 |
nucleotide sequence | 83 |
genome sequences | 83 |
recent studies | 83 |
rna polymerase | 83 |
small interfering | 82 |
binding site | 82 |
heart failure | 82 |
association studies | 82 |
mrna levels | 82 |
tumor growth | 82 |
tumor cell | 82 |
fluorescent protein | 82 |
tumor necrosis | 82 |
start codon | 81 |
gene transcription | 81 |
skeletal muscle | 81 |
acute lung | 81 |
nuclear factor | 81 |
extracellular matrix | 81 |
specific genes | 81 |
mosaic virus | 80 |
results show | 80 |
risk factors | 80 |
protein production | 80 |
lymph nodes | 79 |
real time | 79 |
genome sequencing | 79 |
like particles | 79 |
protein interaction | 78 |
enzyme activity | 78 |
immune cells | 78 |
lymph node | 78 |
systems biology | 78 |
simplex virus | 78 |
hepatocellular carcinoma | 77 |
gi irae | 77 |
normalized shannon | 77 |
based gene | 77 |
essential genes | 77 |
significant increase | 76 |
interfering rna | 76 |
colorectal cancer | 76 |
expression pattern | 76 |
aug codon | 76 |
fatty acid | 76 |
animal model | 76 |
homologous recombination | 76 |
infl uence | 76 |
fold higher | 76 |
exome sequencing | 76 |
pathway analysis | 76 |
dna viruses | 76 |
copy number | 75 |
delivery system | 75 |
sequence data | 75 |
expression studies | 75 |
host cells | 75 |
heat shock | 74 |
syncytial virus | 74 |
cell cultures | 74 |
type diabetes | 74 |
viral rna | 74 |
class ii | 74 |
respiratory syncytial | 74 |
viral gene | 74 |
hek cells | 74 |
mental retardation | 74 |
false discovery | 73 |
also identified | 73 |
expression changes | 73 |
gene product | 73 |
previously reported | 73 |
progenitor cells | 73 |
cell clones | 72 |
rna virus | 72 |
dna repair | 72 |
mammalian cell | 72 |
cells using | 72 |
quality control | 72 |
associated virus | 72 |
human health | 72 |
drug resistance | 71 |
may contribute | 71 |
crispr cas | 71 |
housekeeping genes | 71 |
functional genomics | 71 |
natural killer | 71 |
arabidopsis thaliana | 71 |
adaptive immune | 71 |
also observed | 70 |
like receptors | 70 |
natural selection | 70 |
determine whether | 70 |
public health | 70 |
statistical analysis | 70 |
previously published | 70 |
cell membrane | 70 |
increased expression | 70 |
leaky scanning | 70 |
growth factors | 70 |
clinical trial | 70 |
supplementary material | 70 |
knockout mice | 69 |
diabetes mellitus | 69 |
cell density | 69 |
insect cells | 69 |
serum levels | 69 |
specific expression | 69 |
virus evolution | 69 |
mg ml | 69 |
may play | 69 |
functional analysis | 69 |
specific gene | 69 |
vivo gene | 69 |
expression system | 69 |
lg ml | 69 |
rna sequencing | 68 |
endothelial cell | 68 |
embryonic stem | 68 |
cancer patients | 68 |
genetic variation | 68 |
wide variety | 68 |
protein coding | 68 |
antiviral activity | 68 |
noncoding rna | 68 |
secondary structure | 67 |
may provide | 67 |
two groups | 67 |
current study | 67 |
long noncoding | 67 |
mouse models | 67 |
cdna library | 66 |
coding regions | 66 |
even though | 66 |
cells expressing | 66 |
fi brosis | 66 |
colon cancer | 66 |
sequence similarity | 66 |
protein levels | 66 |
human diseases | 66 |
respiratory distress | 65 |
staphylococcus aureus | 65 |
tyrosine kinase | 65 |
high level | 65 |
respiratory tract | 65 |
proteins involved | 65 |
transcriptome analysis | 65 |
syndrome coronavirus | 65 |
human lung | 65 |
phase ii | 64 |
recent study | 64 |
genetic variants | 64 |
electron microscopy | 64 |
fi ndings | 64 |
several studies | 64 |
different cell | 64 |
cho cells | 64 |
gonadal dysgenesis | 64 |
epithelial cell | 63 |
th century | 63 |
receptor signaling | 63 |
several genes | 63 |
high affinity | 63 |
differential gene | 63 |
protein interactions | 63 |
lactic acid | 63 |
product quality | 63 |
endothelial growth | 62 |
human gene | 62 |
hela cells | 62 |
single cell | 62 |
adrenergic receptor | 62 |
dna binding | 62 |
binding proteins | 62 |
dna polymerase | 62 |
better understanding | 62 |
ca i | 62 |
tunica albuginea | 61 |
transcriptional regulation | 61 |
time rt | 61 |
infectious bronchitis | 61 |
acid residues | 61 |
total number | 61 |
candidate gene | 61 |
cell therapy | 61 |
expression vector | 61 |
genetically modified | 61 |
viral fitness | 60 |
may lead | 60 |
years ago | 60 |
fi tness | 60 |
two genes | 60 |
major histocompatibility | 60 |
coding rnas | 60 |
promoter region | 60 |
blood pressure | 60 |
experimental conditions | 60 |
retroviral vectors | 60 |
single gene | 60 |
gene set | 60 |
infectious disease | 60 |
many genes | 60 |
body weight | 60 |
protein complexes | 60 |
protein gene | 60 |
cell differentiation | 60 |
airway epithelial | 59 |
distress syndrome | 59 |
listeria monocytogenes | 59 |
alternative splicing | 59 |
time quantitative | 59 |
point mutations | 59 |
foreign gene | 59 |
cdna clones | 59 |
untranslated region | 59 |
previous study | 59 |
gene function | 59 |
adenoviral vectors | 59 |
expression systems | 59 |
antimicrobial resistance | 59 |
drug targets | 59 |
genetic engineering | 59 |
growth rate | 59 |
analyzed using | 59 |
acid sequences | 58 |
publicly available | 58 |
fatty acids | 58 |
genes related | 58 |
different tissues | 58 |
es cells | 58 |
small molecule | 58 |
cell populations | 58 |
protein level | 58 |
tissue samples | 58 |
two types | 58 |
biological process | 58 |
high throughput | 58 |
heavy chain | 57 |
human testis | 57 |
epidermal growth | 57 |
host genes | 57 |
metabolic pathways | 57 |
start site | 57 |
previously identified | 57 |
molecular basis | 57 |
mammary gland | 57 |
influenza infection | 57 |
discovery rate | 57 |
noncoding rnas | 57 |
ad vectors | 57 |
coding sequences | 57 |
pcr analysis | 57 |
gene families | 57 |
case report | 57 |
specific primers | 57 |
key role | 56 |
male reproductive | 56 |
recombinant viruses | 56 |
nuclear transfer | 56 |
induced apoptosis | 56 |
disease virus | 56 |
autosomal recessive | 56 |
human genetics | 56 |
cell lung | 56 |
quantitative pcr | 56 |
lipid metabolism | 56 |
commercially available | 56 |
fold increase | 55 |
ef fi | 55 |
testicular biopsy | 55 |
healthy controls | 55 |
increased risk | 55 |
western blotting | 55 |
connective tissue | 55 |
microarray technology | 55 |
structural proteins | 55 |
identified genes | 55 |
vesicular stomatitis | 55 |
cancer gene | 55 |
naturally occurring | 55 |
data indicate | 55 |
national institute | 55 |
leaf curl | 55 |
future studies | 55 |
also used | 55 |
autosomal dominant | 55 |
first step | 55 |
culture medium | 54 |
biological activity | 54 |
small molecules | 54 |
significantly reduced | 54 |
infl ammatory | 54 |
insulin resistance | 54 |
cationic liposomes | 54 |
gene networks | 54 |
four different | 54 |
will also | 54 |
gene targeting | 54 |
binding domain | 54 |
least two | 53 |
target cell | 53 |
hepg cells | 53 |
analysis showed | 53 |
marker genes | 53 |
mast cell | 53 |
speci fi | 53 |
reference genome | 53 |
internal control | 53 |
lung disease | 53 |
similar results | 53 |
selected genes | 53 |
crucial role | 53 |
somatic cell | 52 |
cell tumor | 52 |
transcript abundance | 52 |
resistance gene | 52 |
receptor genes | 52 |
signal peptide | 52 |
cancer treatment | 52 |
inhibitory effect | 52 |
wide association | 52 |
important roles | 52 |
large scale | 52 |
intellectual disability | 52 |
vas deferens | 52 |
fusion proteins | 52 |
mononuclear cells | 52 |
baculovirus vectors | 52 |
disease progression | 52 |
i interferon | 52 |
dna molecules | 52 |
inflammatory cytokines | 52 |
olive flounder | 52 |
cell responses | 52 |
viral genes | 52 |
green fluorescent | 51 |
significantly different | 51 |
male infertility | 51 |
coding region | 51 |
adverse effects | 51 |
also showed | 51 |
genes whose | 51 |
translation initiation | 51 |
human interferon | 51 |
family members | 51 |
infl ammation | 51 |
edible vaccines | 51 |
androgen receptor | 51 |
membrane proteins | 51 |
clinical studies | 51 |
protective effect | 50 |
baculovirus transduction | 50 |
viral dna | 50 |
results obtained | 50 |
allowed us | 50 |
genetically engineered | 50 |
gene coding | 50 |
deficient mice | 50 |
bronchitis virus | 50 |
gi iraes | 50 |
risk assessment | 50 |
low levels | 50 |
living cells | 50 |
stranded dna | 50 |
stomatitis virus | 50 |
sequencing data | 50 |
comparative genomics | 50 |
cultured cells | 50 |
viral genomes | 49 |
tissue engineering | 49 |
brain tissue | 49 |
cellular processes | 49 |
pregnant women | 49 |
standard deviation | 49 |
applied biosystems | 49 |
infl uenza | 49 |
cell receptors | 49 |
septic shock | 49 |
host immune | 49 |
regulatory elements | 49 |
high degree | 49 |
whole blood | 49 |
highly pathogenic | 49 |
sars coronavirus | 48 |
major role | 48 |
negatively charged | 48 |
precocious puberty | 48 |
gene lists | 48 |
cell division | 48 |
chemical engineering | 48 |
present work | 48 |
growth hormone | 48 |
histocompatibility complex | 48 |
rabies virus | 48 |
virus vectors | 48 |
studies showed | 48 |
superoxide dismutase | 48 |
higher levels | 48 |
give rise | 48 |
cell survival | 48 |
technical university | 48 |
using different | 48 |
gene sequences | 48 |
recent advances | 48 |
drug discovery | 48 |
cd cells | 48 |
antigen presentation | 48 |
interfering rnas | 48 |
rna molecules | 47 |
surface antigen | 47 |
early stage | 47 |
statistical complexity | 47 |
comparative analysis | 47 |
somatic cells | 47 |
human cytomegalovirus | 47 |
identify genes | 47 |
viral proteins | 47 |
statistical significance | 47 |
adipose tissue | 47 |
network inference | 47 |
coa racemase | 47 |
identifi ed | 47 |
blood cells | 47 |
three groups | 47 |
fi nding | 47 |
critical role | 47 |
described previously | 47 |
small number | 47 |
one gene | 47 |
sirna delivery | 47 |
significantly lower | 47 |
fruit bat | 47 |
may result | 47 |
sequence alignment | 46 |
cells may | 46 |
human cancer | 46 |
inflammatory responses | 46 |
cationic lipid | 46 |
experimental data | 46 |
small cell | 46 |
clinically relevant | 46 |
ms ms | 46 |
transgenic plants | 46 |
process development | 46 |
light chain | 46 |
myeloid leukemia | 46 |
expression stability | 46 |
model system | 46 |
dna replication | 46 |
plant species | 46 |
pulmonary disease | 46 |
maximum likelihood | 46 |
mean expression | 46 |
therapeutic targets | 46 |
host genome | 46 |
terminal domain | 46 |
disease resistance | 46 |
two major | 46 |
immune genes | 45 |
signalling pathways | 45 |
stop codon | 45 |
cystic fi | 45 |
genes using | 45 |
living beings | 45 |
virulence genes | 45 |
phylogenetic tree | 45 |
cd cd | 45 |
proinflammatory cytokines | 45 |
risk factor | 45 |
presenting cells | 45 |
sanger sequencing | 45 |
coding sequence | 45 |
will help | 45 |
copyright holder | 45 |
membrane protein | 45 |
biologically active | 45 |
molecular characterization | 45 |
cell carcinoma | 44 |
nucleotide polymorphisms | 44 |
genome project | 44 |
cell lymphoma | 44 |
many different | 44 |
cells infected | 44 |
author funder | 44 |
genetic variations | 44 |
recombinant baculovirus | 44 |
alveolar macrophages | 44 |
granted medrxiv | 44 |
cell migration | 44 |
relative expression | 44 |
different genes | 44 |
identified using | 44 |
ankara university | 44 |
targeted gene | 44 |
male pseudohermaphroditism | 44 |
base pairs | 44 |
may cause | 44 |
specific cell | 44 |
hypogonadotropic hypogonadism | 44 |
authors declare | 44 |
deep sequencing | 44 |
environmental factors | 44 |
efficient gene | 44 |
testicular descent | 44 |
outer membrane | 44 |
positive correlation | 44 |
cell wall | 44 |
avian influenza | 44 |
genetic diversity | 44 |
genetic information | 44 |
showed significant | 44 |
airway epithelium | 44 |
recombinant human | 43 |
drug development | 43 |
will provide | 43 |
fi cient | 43 |
takes place | 43 |
fi bers | 43 |
lipid droplets | 43 |
preliminary results | 43 |
novel gene | 43 |
hydrogen peroxide | 43 |
coupled receptors | 43 |
golgi apparatus | 43 |
activated protein | 43 |
genes coding | 43 |
complete genome | 43 |
whose expression | 43 |
androgen insensitivity | 43 |
eukaryotic cells | 43 |
molecular level | 43 |
cell population | 43 |
structural protein | 43 |
recombinant dna | 43 |
wound healing | 43 |
ali ards | 43 |
quantitative rt | 43 |
affinity chromatography | 43 |
sequence identity | 43 |
findings suggest | 42 |
chinese hamster | 42 |
better understand | 42 |
messenger rna | 42 |
genetic polymorphisms | 42 |
two distinct | 42 |
mechanisms underlying | 42 |
host responses | 42 |
dna sequencing | 42 |
protein sequences | 42 |
dengue virus | 42 |
foreign genes | 42 |
reproductive tissue | 42 |
genes may | 42 |
melanoma cells | 42 |
aug codons | 42 |
airway inflammation | 42 |
protein complex | 42 |
lipid peroxidation | 42 |
clinical symptoms | 42 |
expressed gene | 42 |
zinc finger | 42 |
last years | 42 |
signalling pathway | 42 |
multiple sclerosis | 42 |
least stable | 41 |
external genitalia | 41 |
cdna synthesis | 41 |
pharmakologie und | 41 |
surface receptors | 41 |
gene co | 41 |
transgenic animals | 41 |
biological systems | 41 |
expression values | 41 |
protein sequence | 41 |
neutralizing antibodies | 41 |
treated cells | 41 |
well known | 41 |
nucleotide sequences | 41 |
target protein | 41 |
dna vaccination | 41 |
toxic effects | 41 |
dna microarrays | 41 |
bacillus subtilis | 41 |
capsid protein | 41 |
consensus sequence | 41 |
type iii | 41 |
version posted | 41 |
long term | 41 |
biomedical research | 41 |
positive cells | 41 |
associated protein | 41 |
supplementary file | 41 |
cancer stem | 41 |
blood mononuclear | 41 |
systems medicine | 41 |
identifi cation | 41 |
mrna stability | 41 |
days post | 40 |
recombinant vaccinia | 40 |
transcriptional activation | 40 |
human cell | 40 |
life sciences | 40 |
cell development | 40 |
studies using | 40 |
chicken genome | 40 |
results demonstrate | 40 |
different species | 40 |
viral vector | 40 |
data obtained | 40 |
stable gene | 40 |
respiratory viruses | 40 |
i molecules | 40 |
coat protein | 40 |
negative control | 40 |
cho cell | 40 |
cell response | 40 |
cells via | 40 |
short stature | 40 |
novel genes | 40 |
viral diseases | 40 |
candidate reference | 40 |
hiv infection | 40 |
calculated using | 40 |
neuronal cells | 40 |
biological functions | 40 |
blood vessels | 40 |
killer cell | 39 |
time course | 39 |
containing genes | 39 |
testicular microlithiasis | 39 |
cardiovascular diseases | 39 |
neuropathic pain | 39 |
muscular dystrophy | 39 |
network analysis | 39 |
und toxikologie | 39 |
significantly enriched | 39 |
cd expression | 39 |
different time | 39 |
sustentacular cells | 39 |
membrane potential | 39 |
cellular uptake | 39 |
lung tissue | 39 |
cell biology | 39 |
stress response | 39 |
may affect | 39 |
another study | 39 |
also shown | 39 |
using gene | 39 |
receptor complex | 39 |
coli strains | 39 |
metabolic engineering | 39 |
located within | 39 |
genetic factors | 39 |
disease severity | 39 |
pcr products | 38 |
dna microarray | 38 |
rate variation | 38 |
clinical practice | 38 |
many studies | 38 |
nk cell | 38 |
nasal epithelium | 38 |
naked dna | 38 |
dna complexes | 38 |
bacterial infection | 38 |
cmv promoter | 38 |
lung function | 38 |
differentially regulated | 38 |
host factors | 38 |
accession number | 38 |
shannon divergence | 38 |
essential role | 38 |
virus genome | 38 |
cytokine production | 38 |
cell function | 38 |
vaccine development | 38 |
pcr amplification | 38 |
relatively low | 38 |
reporter genes | 38 |
carbon source | 38 |
multiple genes | 37 |
ovarian cancer | 37 |
hierarchical clustering | 37 |
environmental conditions | 37 |
cell hyperplasia | 37 |
unknown function | 37 |
genomic data | 37 |
middle east | 37 |
throughput sequencing | 37 |
cell gene | 37 |
coupled receptor | 37 |
clinical features | 37 |
new therapeutic | 37 |
full length | 37 |
pancreatic cancer | 37 |
suppressor genes | 37 |
thymidine kinase | 37 |
mitochondrial membrane | 37 |
data using | 37 |
expression omnibus | 37 |
long time | 37 |
human breast | 37 |
pulmonary gene | 37 |
broad range | 37 |
therapeutic strategies | 37 |
stable reference | 37 |
low molecular | 37 |
clinical isolates | 37 |
enzyme activities | 37 |
two proteins | 37 |
receptor expression | 37 |
fever virus | 37 |
hamster ovary | 37 |
protein genes | 37 |
correlation coefficient | 37 |
successfully used | 37 |
differentially methylated | 37 |
significantly associated | 37 |
play important | 37 |
machine learning | 37 |
serum samples | 36 |
stable genes | 36 |
control genes | 36 |
significant reduction | 36 |
situ hybridization | 36 |
experimental design | 36 |
upregulated genes | 36 |
inhibitory effects | 36 |
developmental stages | 36 |
west nile | 36 |
culture media | 36 |
long non | 36 |
cells showed | 36 |
branch lengths | 36 |
heart disease | 36 |
control groups | 36 |
regulatory networks | 36 |
clinical data | 36 |
control gene | 36 |
gives rise | 36 |
may represent | 36 |
enrichment analyses | 36 |
developmental delay | 36 |
target rna | 36 |
probe sets | 36 |
strand breaks | 36 |
omics data | 36 |
adenoviral vector | 36 |
positively charged | 36 |
citric acid | 36 |
nonhuman primates | 36 |
made available | 36 |
stop codons | 36 |
gene mutations | 36 |
pulmonary fibrosis | 36 |
three genes | 36 |
caenorhabditis elegans | 36 |
many cases | 36 |
like protein | 36 |
liquid chromatography | 36 |
culture conditions | 36 |
therapeutic potential | 36 |
several different | 36 |
beta cells | 36 |
northern blot | 36 |
high frequency | 36 |
stable expression | 36 |
results revealed | 35 |
molecular cloning | 35 |
ribosomal protein | 35 |
measured using | 35 |
hepatitis virus | 35 |
genes within | 35 |
humoral immune | 35 |
synthetic peptides | 35 |
spleen cells | 35 |
therapeutic gene | 35 |
splice site | 35 |
effi cacy | 35 |
infertile men | 35 |
multidrug resistance | 35 |
adhesion molecules | 35 |
molecular genetic | 35 |
virus particles | 35 |
one another | 35 |
using real | 35 |
adrenal hyperplasia | 35 |
gene regulatory | 35 |
cycle arrest | 35 |
new insights | 35 |
may help | 35 |
life cycle | 35 |
agarose gel | 35 |
also involved | 35 |
peer review | 35 |
increased levels | 35 |
spermatic cord | 35 |
limited number | 35 |
human prostate | 35 |
induced lung | 35 |
expression vectors | 35 |
large numbers | 35 |
dn ds | 35 |
evaluated using | 35 |
related species | 34 |
feature selection | 34 |
kegg pathway | 34 |
pluripotent stem | 34 |
positively correlated | 34 |
molecular analysis | 34 |
significant genes | 34 |
bipolar disorder | 34 |
protein function | 34 |
signifi cant | 34 |
upstream aug | 34 |
nonviral gene | 34 |
human ifn | 34 |
fibroblast growth | 34 |
cryptorchid testes | 34 |
generated using | 34 |
seq analysis | 34 |
vitro studies | 34 |
defi cient | 34 |
ribosomal rna | 34 |
flying fox | 34 |
antiviral response | 34 |
pearson correlation | 34 |
significantly decreased | 34 |
cellular immune | 34 |
genes expressed | 34 |
based approach | 34 |
nucleotide substitutions | 34 |
embryonic development | 34 |
host defense | 34 |
suicide gene | 34 |
secondary metabolites | 34 |
negative bacteria | 34 |
dendritic cell | 34 |
regulatory factor | 34 |
high expression | 34 |
complex diseases | 34 |
solid tumors | 34 |
genome analysis | 34 |
stimulated genes | 34 |
echolocating bats | 34 |
much higher | 34 |
cell embryos | 33 |
comparative genomic | 33 |
defi cit | 33 |
cells compared | 33 |
pattern recognition | 33 |
microarray experiments | 33 |
large amounts | 33 |
reperfusion injury | 33 |
adhesion molecule | 33 |
key genes | 33 |
drinking water | 33 |
barr virus | 33 |
classifi ed | 33 |
ebola virus | 33 |
angiotensin ii | 33 |
coding gene | 33 |
protein kinases | 33 |
first aug | 33 |
cohesin genes | 33 |
great leaf | 33 |
intensive care | 33 |
infected pigs | 33 |
edible vaccine | 33 |
highly efficient | 33 |
gene sets | 33 |
different methods | 33 |
kegg pathways | 33 |
primary human | 33 |
rat brain | 33 |
virus infections | 33 |
bovine serum | 33 |
scientific community | 33 |
dna delivery | 33 |
significant pathways | 33 |
normal human | 33 |
cdna clone | 33 |
usage bias | 33 |
cardiovascular disease | 33 |
adverse events | 33 |
ribosomal frameshifting | 33 |
vascular smooth | 33 |
science foundation | 33 |
stromal cells | 33 |
gene list | 33 |
transfected cells | 33 |
bacterial infections | 33 |
interferon regulatory | 33 |
pcr data | 33 |
inflammatory cells | 33 |
accession numbers | 33 |
may occur | 33 |
point mutation | 33 |
cationic lipids | 33 |
comparison groups | 33 |
whole exome | 33 |
gene encodes | 33 |
samples collected | 33 |
brain barrier | 32 |
chronic inflammation | 32 |
lung epithelial | 32 |
also associated | 32 |
scanning mechanism | 32 |
central role | 32 |
nile virus | 32 |
transcriptional changes | 32 |
two novel | 32 |
baculovirus expressing | 32 |
early stages | 32 |
biological pathways | 32 |
first report | 32 |
signi fi | 32 |
antibody production | 32 |
glioma cells | 32 |
obtained using | 32 |
early onset | 32 |
promoter activity | 32 |
specific antigen | 32 |
crystal structure | 32 |
like cells | 32 |
proteins encoded | 32 |
low cost | 32 |
cell entry | 32 |
squamous cell | 32 |
pathway enrichment | 32 |
investigated using | 32 |
research institute | 32 |
phosphate dehydrogenase | 32 |
tomato leaf | 32 |
new drugs | 32 |
also present | 32 |
envelope protein | 32 |
assessed using | 32 |
might also | 32 |
testicular parenchyma | 32 |
gastric cancer | 32 |
animal species | 32 |
asymmetric evolution | 32 |
transmembrane protein | 32 |
results indicated | 32 |
data show | 32 |
exact test | 31 |
poorly understood | 31 |
acid production | 31 |
enzymatic activity | 31 |
response genes | 31 |
fold changes | 31 |
missense mutations | 31 |
antibody response | 31 |
antisense oligonucleotides | 31 |
near future | 31 |
th cells | 31 |
baculovirus vector | 31 |
cancer progression | 31 |
transmembrane proteins | 31 |
infection control | 31 |
inflammatory bowel | 31 |
genome assembly | 31 |
individual genes | 31 |
expression analyses | 31 |
autographa californica | 31 |
potential role | 31 |
four groups | 31 |
protective effects | 31 |
viral particles | 31 |
possible role | 31 |
lipid rafts | 31 |
biofilm formation | 31 |
testicular cancer | 31 |
suppressor gene | 31 |
various types | 31 |
target proteins | 31 |
regulatory mechanisms | 31 |
genetic analysis | 31 |
tobacco plants | 31 |
will allow | 31 |
healthy individuals | 31 |
quantitative analysis | 31 |
confocal microscopy | 31 |
chronic obstructive | 31 |
low concentrations | 31 |
different concentrations | 31 |
baculovirus expression | 31 |
high concentrations | 31 |
serum albumin | 31 |
synthetic biology | 31 |
particular interest | 31 |
plants infected | 31 |
nude mice | 31 |
wastewater treatment | 31 |
host gene | 31 |
room temperature | 31 |
virulence factors | 31 |
negative selection | 31 |
common ancestor | 30 |
acute myeloid | 30 |
among others | 30 |
sequence variants | 30 |
two main | 30 |
using two | 30 |
novo assembly | 30 |
nucleotide polymorphism | 30 |
significant association | 30 |
foreign dna | 30 |
using rna | 30 |
negative correlation | 30 |
steady state | 30 |
viable cell | 30 |
identify novel | 30 |
serine protease | 30 |
interaction network | 30 |
mechanisms involved | 30 |
research council | 30 |
clostridium difficile | 30 |
severe disease | 30 |
recombinant virus | 30 |
pseudomonas aeruginosa | 30 |
testicular biopsies | 30 |
material online | 30 |
pharmaceutical industry | 30 |
associated gene | 30 |
human embryonic | 30 |
viral protein | 30 |
cytotoxic effects | 30 |
strand rna | 30 |
basic research | 30 |
expression cassettes | 30 |
fl uid | 30 |
molecular mass | 30 |
bat species | 30 |
paralichthys olivaceus | 30 |
derived growth | 30 |
gene sequence | 30 |
gene network | 30 |
vaccine delivery | 30 |
specific antibodies | 30 |
may serve | 30 |
results demonstrated | 30 |
increasing number | 30 |
see chapter | 30 |
autoimmune diseases | 30 |
nuclear localization | 30 |
cell rna | 30 |
transforming growth | 30 |
mouse brain | 30 |
dna strand | 30 |
much lower | 30 |
cell imaging | 30 |
differential diagnosis | 30 |
gene stability | 30 |
related gene | 30 |
gene selection | 30 |
relatively high | 30 |
based approaches | 30 |
mouth disease | 30 |
family history | 30 |
cells derived | 30 |
large dna | 30 |
transduction pathways | 30 |
apoptotic cell | 29 |
suitable reference | 29 |
significant role | 29 |
gene cluster | 29 |
host range | 29 |
highly specific | 29 |
fermentation process | 29 |
coronavirus infection | 29 |
oxygen transfer | 29 |
adenosine deaminase | 29 |
fi eld | 29 |
programmed cell | 29 |
chapter iv | 29 |
dose dependent | 29 |
global gene | 29 |
neuronal cell | 29 |
airway epithelia | 29 |
different levels | 29 |
patients treated | 29 |
signifi cantly | 29 |
like gene | 29 |
acid substitutions | 29 |
mouse hepatitis | 29 |
microarray studies | 29 |
broad spectrum | 29 |
fruit bats | 29 |
antibody responses | 29 |
information theory | 29 |
transcriptional control | 29 |
cells within | 29 |
vero cells | 29 |
top genes | 29 |
density lipoprotein | 29 |
new generation | 29 |
elevated levels | 29 |
mouse ifn | 29 |
autism spectrum | 29 |
may indicate | 29 |
genomic regions | 29 |
premature stop | 29 |
insect cell | 29 |
different stages | 29 |
signifi cance | 29 |
based therapies | 29 |
another example | 29 |
stimulating factor | 29 |
international license | 29 |
carcinoma cells | 29 |
life technologies | 29 |
response element | 29 |
highly variable | 29 |
initiation factor | 29 |
circadian period | 29 |
time series | 29 |
viral pathogens | 29 |
drosophila melanogaster | 29 |
biological replicates | 29 |
active site | 29 |
streptococcus pneumoniae | 29 |
internal controls | 29 |
human skin | 29 |
new genes | 29 |
cluster analysis | 29 |
studies revealed | 29 |
fi ciency | 29 |
protein encoded | 29 |
shock protein | 29 |
translational control | 29 |
rhinolophoid bats | 29 |
diseases like | 29 |
influenza viruses | 29 |
genetic basis | 29 |
host proteins | 29 |
egyptian fruit | 29 |
interacting protein | 29 |
antioxidant status | 29 |
lung diseases | 29 |
inducible gene | 29 |
acid composition | 29 |
molecular function | 29 |
bispecific antibodies | 29 |
human host | 29 |
last decade | 28 |
done using | 28 |
aav vectors | 28 |
cytotoxic effect | 28 |
dna encoding | 28 |
stress conditions | 28 |
transcriptional activity | 28 |
high risk | 28 |
analysis results | 28 |
dependent protein | 28 |
illumina hiseq | 28 |
clinical disease | 28 |
clonal cell | 28 |
molecular genetics | 28 |
genes showed | 28 |
phosphorylation sites | 28 |
high density | 28 |
positively selected | 28 |
converting enzyme | 28 |
expression differences | 28 |
mediated endocytosis | 28 |
transcriptome data | 28 |
nucleocapsid protein | 28 |
genetic manipulation | 28 |
bacterial species | 28 |
mycobacterium tuberculosis | 28 |
pol gene | 28 |
transcriptional units | 28 |
protective immunity | 28 |
asthma patients | 28 |
positive bacteria | 28 |
infectious agents | 28 |
fat diet | 28 |
compound heterozygous | 28 |
gene panel | 28 |
bacterial pathogens | 28 |
primary cells | 28 |
cell nucleus | 28 |
neurodegenerative diseases | 28 |
leukemia virus | 28 |
multiple sequence | 28 |
clinical use | 28 |
domestic cat | 28 |
susceptibility genes | 28 |
mitochondrial genome | 28 |
therapeutic proteins | 28 |
gene symbols | 28 |
primary spermatocytes | 28 |
cancer immunotherapy | 28 |
posterior probabilities | 28 |
cell expression | 28 |
disease genes | 28 |
novel therapeutic | 28 |
functional role | 28 |
control cells | 28 |
high resolution | 28 |
chronic diseases | 28 |
insertional mutagenesis | 28 |
testicular torsion | 28 |
fluorescent proteins | 28 |
gene therapies | 28 |
antioxidant capacity | 28 |
sequence alignments | 28 |
annotated genes | 28 |
cancer types | 28 |
dna synthesis | 28 |
rat liver | 28 |
plant viruses | 28 |
fi brous | 28 |
mdv infection | 28 |
virus genomes | 28 |
metal ions | 28 |
study showed | 28 |
low expression | 28 |
pivotal role | 28 |
plants expressing | 28 |
biochemical parameters | 28 |
bowel disease | 28 |
comet assay | 28 |
soluble protein | 28 |
hub genes | 28 |
higher level | 28 |
great potential | 28 |
take place | 28 |
genetic elements | 28 |
rna samples | 28 |
cytoplasmic tail | 28 |
molecular mechanism | 28 |
genes based | 28 |
hematopoietic stem | 28 |
san diego | 27 |
swine fever | 27 |
general population | 27 |
recent developments | 27 |
selective pressure | 27 |
cell epitopes | 27 |
remains unclear | 27 |
digital gene | 27 |
actin cytoskeleton | 27 |
biological networks | 27 |
regulatory regions | 27 |
rheumatoid arthritis | 27 |
tk gene | 27 |
tumor progression | 27 |
irae group | 27 |
inflammatory diseases | 27 |
positive control | 27 |
expressing cells | 27 |
kg day | 27 |
tandem mass | 27 |
among different | 27 |
genetic disorders | 27 |
target effects | 27 |
currently available | 27 |
cns disorders | 27 |
probability distribution | 27 |
bronchoalveolar lavage | 27 |
animal care | 27 |
bl mice | 27 |
transduced cells | 27 |
transcriptional response | 27 |
high quality | 27 |
antigen presenting | 27 |
systemic administration | 27 |
surface expression | 27 |
male fertility | 27 |
rna transcription | 27 |
obstructive pulmonary | 27 |
ethylene glycol | 27 |
genetic resources | 27 |
xy gonadal | 27 |
natural products | 27 |
experimental method | 27 |
evidence suggests | 27 |
lung cancers | 27 |
lung tissues | 27 |
functional characterization | 27 |
human chromosome | 27 |
rna silencing | 27 |
codon position | 27 |
aspergillus niger | 27 |
scientific research | 27 |
genetic code | 27 |
one hand | 27 |
rna isolation | 27 |
biological function | 27 |
three times | 27 |
genetic studies | 27 |
gene mutation | 27 |
tissue damage | 27 |
stimulated gene | 27 |
hepatoma cells | 27 |
times higher | 27 |
competing interests | 27 |
total protein | 27 |
pcr using | 27 |
group i | 27 |
fi ed | 27 |
past years | 27 |
hlh genes | 27 |
following infection | 27 |
camel species | 27 |
split inteins | 27 |
jak stat | 27 |
ic values | 27 |
transcriptional level | 27 |
japanese encephalitis | 27 |
myocardial infarction | 27 |
lymphoid organs | 27 |
molecular pathways | 27 |
combination therapy | 27 |
diabetic patients | 27 |
rna genome | 27 |
three major | 27 |
relative risk | 27 |
enriched pathways | 26 |
defi ned | 26 |
first study | 26 |
gene knockdown | 26 |
investigate whether | 26 |
major cause | 26 |
phylogenetic trees | 26 |
cas system | 26 |
zebrafish embryos | 26 |
drug administration | 26 |
control subjects | 26 |
inserted sequences | 26 |
transfer vectors | 26 |
linkage disequilibrium | 26 |
respiratory disease | 26 |
set enrichment | 26 |
potential therapeutic | 26 |
sequence information | 26 |
small rna | 26 |
tubular hyalinization | 26 |
surface protein | 26 |
liver tissue | 26 |
genome annotation | 26 |
derived mesenchymal | 26 |
decreased expression | 26 |
single dose | 26 |
adenovirus vectors | 26 |
throughput screening | 26 |
developing countries | 26 |
recently shown | 26 |
missense mutation | 26 |
gene duplication | 26 |
pathogenic bacteria | 26 |
mirna expression | 26 |
control samples | 26 |
new reference | 26 |
least three | 26 |
protein structure | 26 |
polyethylene glycol | 26 |
well characterized | 26 |
motor neurons | 26 |
directed mutagenesis | 26 |
mtor signaling | 26 |
ang ii | 26 |
resistance mechanisms | 26 |
lipid bilayer | 26 |
energy metabolism | 26 |
genome browser | 26 |
clinical signs | 26 |
human protein | 26 |
evolutionary biology | 26 |
mammalian species | 26 |
rational design | 26 |
genetic diseases | 26 |
tumor tissue | 26 |
significant effect | 26 |
analysis tools | 26 |
systemic inflammation | 26 |
prrsv rjxwn | 26 |
catalytic activity | 26 |
cervical cancer | 26 |
study revealed | 26 |
like domains | 26 |
clinical samples | 26 |
per se | 26 |
functional studies | 26 |
cftr gene | 26 |
see also | 26 |
excretory ducts | 26 |
free radical | 26 |
human airway | 26 |
coding rna | 26 |
high dose | 26 |
sensory neurons | 26 |
capsid proteins | 26 |
showed high | 26 |
induced pluripotent | 26 |
induces apoptosis | 26 |
genomic sequence | 26 |
studies suggest | 26 |
delivery vehicles | 26 |
transcriptional activator | 26 |
also demonstrated | 26 |
brain development | 26 |
tissue culture | 26 |
medium containing | 26 |
seminiferous epithelium | 26 |
antimicrobial activity | 26 |
molecular dynamics | 26 |
sample size | 26 |
using microarrays | 26 |
exogenous dna | 26 |
testicular lesions | 26 |
vast majority | 26 |
adaptive evolution | 25 |
study group | 25 |
cl contig | 25 |
mouse genes | 25 |
genomic organization | 25 |
treatment strategies | 25 |
acute phase | 25 |
trb genes | 25 |
strand cdna | 25 |
induced gene | 25 |
association study | 25 |
leading cause | 25 |
ifitm genes | 25 |
provide evidence | 25 |
cycle progression | 25 |
reduced expression | 25 |
therapeutic genes | 25 |
various diseases | 25 |
treatment group | 25 |
multiple testing | 25 |
comprehensive analysis | 25 |
dna samples | 25 |
genetic risk | 25 |
cytokine receptor | 25 |
also show | 25 |
alkaline phosphatase | 25 |
complex formation | 25 |
hearing loss | 25 |
cord blood | 25 |
expression value | 25 |
immunosorbent assay | 25 |
cells ml | 25 |
using high | 25 |
subcellular localization | 25 |
spike protein | 25 |
two species | 25 |
salmonella typhimurium | 25 |
normal samples | 25 |
cancer research | 25 |
highly sensitive | 25 |
clinical applications | 25 |
viral disease | 25 |
dawley rats | 25 |
rr ij | 25 |
sevenband grouper | 25 |
cellular response | 25 |
ibv infection | 25 |
mouse lung | 25 |
cells per | 25 |
significant decrease | 25 |
usage pattern | 25 |
higher expression | 25 |
mutation rate | 25 |
viral entry | 25 |
previously shown | 25 |
specific group | 25 |
nnv infection | 25 |
virulence gene | 25 |
evolutionarily conserved | 25 |
particle size | 25 |
critically ill | 25 |
among genes | 25 |
olfactory bulb | 25 |
transduction efficiency | 25 |
experimental studies | 25 |
thermo fisher | 25 |
bladder cancer | 25 |
coronavirus disease | 25 |
testicular function | 25 |
cst gene | 25 |
cdna libraries | 25 |
may increase | 25 |
regulatory proteins | 25 |
transgenic mouse | 25 |
novel coronavirus | 25 |
induced ali | 25 |
nk cells | 25 |
great interest | 25 |
sperm excretory | 25 |
level expression | 25 |
farm animals | 25 |
university hospital | 25 |
clinical outcome | 25 |
pathways involved | 25 |
functional annotation | 25 |
data types | 25 |
enzymes involved | 25 |
biological activities | 25 |
murine model | 25 |
cell lysates | 24 |
salmonella enterica | 24 |
different experimental | 24 |
protein coupled | 24 |
dysregulated genes | 24 |
significant correlation | 24 |
also detected | 24 |
replacement therapy | 24 |
heavy metals | 24 |
different doses | 24 |
sarcoma virus | 24 |
adaptive immunity | 24 |
acid binding | 24 |
therapeutic agents | 24 |
nosed bat | 24 |
lysosomal storage | 24 |
years old | 24 |
provide insight | 24 |
drug metabolism | 24 |
horizontal gene | 24 |
transcript levels | 24 |
autoimmune disease | 24 |
next step | 24 |
recently identified | 24 |
genomic sequences | 24 |
defense mechanisms | 24 |
salivary glands | 24 |
study design | 24 |
study provides | 24 |
genes will | 24 |
metabolic processes | 24 |
negative regulator | 24 |
genbank accession | 24 |
systematic review | 24 |
well established | 24 |
vascular permeability | 24 |
clinical application | 24 |
plant growth | 24 |
sequence homology | 24 |
constructed using | 24 |
dna fragments | 24 |
intronless genes | 24 |
national center | 24 |
increased susceptibility | 24 |
horseshoe bat | 24 |
low level | 24 |
elongation factor | 24 |
therapeutic applications | 24 |
targeted delivery | 24 |
expressed sequence | 24 |
profi les | 24 |
transcriptomic analysis | 24 |
antiviral immunity | 24 |
olfactory epithelium | 24 |
previous work | 24 |
binding affinity | 24 |
surface area | 24 |
group compared | 24 |
vector system | 24 |
systemic delivery | 24 |
specific targeting | 24 |
oxide synthase | 24 |
common bean | 24 |
normal cells | 24 |
double strand | 24 |
disease pathogenesis | 24 |
bacterial genomes | 24 |
ifitm proteins | 24 |
gene expressions | 24 |
expression networks | 24 |
interaction networks | 24 |
two strains | 24 |
regulatory genes | 24 |
different conditions | 24 |
liver cancer | 24 |
synonymous mutation | 24 |
clinical presentation | 24 |
recombination events | 24 |
per year | 24 |
much less | 24 |
function mutations | 24 |
often used | 24 |
study will | 24 |
genes among | 24 |
age groups | 24 |
recently described | 24 |
nadph oxidase | 24 |
analysis reveals | 24 |
receptor binding | 24 |
total antioxidant | 24 |
potential use | 24 |
findings indicate | 24 |
new technologies | 24 |
gene promoter | 24 |
expressed proteins | 24 |
glutathione peroxidase | 24 |
allele frequency | 24 |
related protein | 24 |
inhibitory activity | 24 |
data demonstrate | 24 |
using specific | 24 |
weight loss | 24 |
encoding genes | 24 |
testicular dysgenesis | 24 |
human leukocyte | 24 |
i ifn | 24 |
old world | 23 |
new drug | 23 |
economic losses | 23 |
tubular diameter | 23 |
genes across | 23 |
frequently used | 23 |
antioxidant activity | 23 |
kda protein | 23 |
three types | 23 |
molecular pathology | 23 |
affected individuals | 23 |
human cancers | 23 |
one case | 23 |
linked immunosorbent | 23 |
model organisms | 23 |
genomic analysis | 23 |
genetic testing | 23 |
dependent rna | 23 |
marker gene | 23 |
binding domains | 23 |
antitumor activity | 23 |
national institutes | 23 |
poor prognosis | 23 |
genes exhibiting | 23 |
cellular component | 23 |
expression using | 23 |
per cell | 23 |
gene interaction | 23 |
provide new | 23 |
kinase inhibitor | 23 |
will enable | 23 |
also possible | 23 |
also called | 23 |
powerful tool | 23 |
alternatively spliced | 23 |
also play | 23 |
significant changes | 23 |
genetic modification | 23 |
strains isolated | 23 |
identified several | 23 |
severe asthma | 23 |
recognition receptors | 23 |
creative commons | 23 |
virus strain | 23 |
glutamic acid | 23 |
across different | 23 |
specific cd | 23 |
small nucleolar | 23 |
chemokine receptor | 23 |
expression profi | 23 |
log fold | 23 |
base pair | 23 |
allows us | 23 |
transgenic animal | 23 |
mtt assay | 23 |
nuclear import | 23 |
encephalitis virus | 23 |
dividing cells | 23 |
well tolerated | 23 |
rna structure | 23 |
binding activity | 23 |
bacterial cells | 23 |
will require | 23 |
several groups | 23 |
plant cells | 23 |
artificial chromosome | 23 |
gene variants | 23 |
guanine nucleotide | 23 |
gene segments | 23 |
mean age | 23 |
host evolution | 23 |
vector expressing | 23 |
infertile patients | 23 |
negatively correlated | 23 |
evolutionary history | 23 |
deletion mutants | 23 |
cardiac hypertrophy | 23 |
kinase activity | 23 |
cellular responses | 23 |
ubiquitously expressed | 23 |
rna integrity | 23 |
live cell | 23 |
one patient | 23 |
vivo studies | 23 |
gave rise | 23 |
delivery vectors | 23 |
efficient delivery | 23 |
infected plants | 23 |
also revealed | 23 |
split dnae | 23 |
raw data | 23 |
usage patterns | 23 |
may influence | 23 |
yeast cells | 23 |
diabetic rats | 23 |
serial analysis | 23 |
virus glycoprotein | 23 |
culture supernatants | 23 |
antisense strand | 23 |
genetic association | 23 |
rnase iii | 23 |
statistical methods | 23 |
also performed | 23 |
signaling molecules | 23 |
cellular functions | 23 |
split intein | 23 |
healthy subjects | 23 |
giving rise | 23 |
preliminary data | 23 |
lamina propria | 23 |
healthy volunteers | 23 |
genetic stability | 23 |
microarray gene | 23 |
mrna level | 23 |
endosomal escape | 23 |
alternative approach | 22 |
i clinical | 22 |
kidney disease | 22 |
potential drug | 22 |
transcriptome sequencing | 22 |
leader sequence | 22 |
renal failure | 22 |
medical school | 22 |
close proximity | 22 |
gene finding | 22 |
white blood | 22 |
accurate normalization | 22 |
extensively studied | 22 |
cancer development | 22 |
elastic fi | 22 |
health care | 22 |
reverse genetics | 22 |
dna technology | 22 |
modi fi | 22 |
valproic acid | 22 |
quantified using | 22 |
cell membranes | 22 |
specific transcripts | 22 |
undescended testes | 22 |
common cause | 22 |
gene clusters | 22 |
diffi cult | 22 |
growth retardation | 22 |
splice variants | 22 |
expression across | 22 |
cells also | 22 |
cell densities | 22 |
biological samples | 22 |
recently developed | 22 |
use committee | 22 |
radical prostatectomy | 22 |
gene interactions | 22 |
intravenous injection | 22 |
pcr results | 22 |
releasing hormone | 22 |
structural changes | 22 |
transgenic zebrafish | 22 |
internal initiation | 22 |
uric acid | 22 |
feline coronavirus | 22 |
abiotic stress | 22 |
secretory pathway | 22 |
mouse genome | 22 |
virus vector | 22 |
seminiferous tubule | 22 |
carcinoma cell | 22 |
expression cassette | 22 |
also reported | 22 |
rice tungro | 22 |
mutation carriers | 22 |
mediated delivery | 22 |
rna binding | 22 |
flow cytometric | 22 |
rna editing | 22 |
altered expression | 22 |
sample preparation | 22 |
human epididymis | 22 |
lung adenocarcinoma | 22 |
data generated | 22 |
induced genes | 22 |
therapeutic effect | 22 |
type cells | 22 |
resistant bacteria | 22 |
results will | 22 |
large quantities | 22 |
rna extraction | 22 |
clinical manifestations | 22 |
testicular enlargement | 22 |
wavelet based | 22 |
economically important | 22 |
immune cell | 22 |
sperm motility | 22 |
proteins may | 22 |
study demonstrated | 22 |
specific protein | 22 |
restriction sites | 22 |
another important | 22 |
two patients | 22 |
essential gene | 22 |
highly correlated | 22 |
pcr assay | 22 |
maturation arrest | 22 |
specific antibody | 22 |
factor gene | 22 |
bronchial epithelial | 22 |
proteomic analysis | 22 |
energy transfer | 22 |
data mining | 22 |
complementary dna | 22 |
highly enriched | 22 |
myofi broblasts | 22 |
genes might | 22 |
human blood | 22 |
identify potential | 22 |
fisher scientific | 22 |
lung cells | 22 |
protein binding | 22 |
plasmodium falciparum | 22 |
recombinant baculoviruses | 22 |
genomic rna | 22 |
new species | 22 |
factors involved | 22 |
way anova | 22 |
posted september | 22 |
delivery methods | 22 |
estrogen receptor | 22 |
cell maturation | 22 |
hours post | 22 |
apoptotic cells | 22 |
interferon gene | 22 |
human genetic | 22 |
transcriptional regulator | 22 |
ethanol production | 22 |
become available | 21 |
tissue types | 21 |
detected using | 21 |
immune systems | 21 |
world health | 21 |
nuclear polyhedrosis | 21 |
experimental evidence | 21 |
transient expression | 21 |
using pcr | 21 |
regulatory protein | 21 |
macaque genome | 21 |
elevated serum | 21 |
therapeutic effects | 21 |
baculoviral vectors | 21 |
small intestine | 21 |
yeast extract | 21 |
across multiple | 21 |
per day | 21 |
inhibitory factor | 21 |
bat transcriptome | 21 |
five different | 21 |
constitutively expressed | 21 |
structural genes | 21 |
umbilical cord | 21 |
steroid hormones | 21 |
fluorescence microscopy | 21 |
chronic inflammatory | 21 |
well plates | 21 |
shed light | 21 |
cytotoxic activity | 21 |
mesenchymal transition | 21 |
genome editing | 21 |
mammalian gene | 21 |
many years | 21 |
showed increased | 21 |
dna fragment | 21 |
messenger rnas | 21 |
contralateral testis | 21 |
will become | 21 |
bcg vaccination | 21 |
reference sequence | 21 |
protein folding | 21 |
genome sizes | 21 |
free medium | 21 |
mediated immunity | 21 |
fully understood | 21 |
protein nanoparticles | 21 |
two samples | 21 |
neutralizing antibody | 21 |
cells without | 21 |
basal lamina | 21 |
now available | 21 |
batch culture | 21 |
acute lymphoblastic | 21 |
cell counts | 21 |
ncbi reference | 21 |
specific immune | 21 |
russian science | 21 |
epidemiological studies | 21 |
inflammatory mediators | 21 |
biology approach | 21 |
specific dna | 21 |
aug start | 21 |
rat model | 21 |
organ dysfunction | 21 |
congenital adrenal | 21 |
cells grown | 21 |
like growth | 21 |
line development | 21 |
gene usage | 21 |
molecular markers | 21 |
specific binding | 21 |
male mice | 21 |
lymphoblastic leukemia | 21 |
scale production | 21 |
respiratory failure | 21 |
genome organization | 21 |
one year | 21 |
conducted using | 21 |
hairpin rna | 21 |
available data | 21 |
regression analysis | 21 |
dwarf virus | 21 |
national cancer | 21 |
tissue type | 21 |
large amount | 21 |
leukocyte receptor | 21 |
four times | 21 |
vp gene | 21 |
cell numbers | 21 |
one study | 21 |
polyhedrosis virus | 21 |
dorsal root | 21 |
lactate dehydrogenase | 21 |
ligand binding | 21 |
cbnp exposure | 21 |
protective role | 21 |
cell fusion | 21 |
alveolar epithelial | 21 |
using three | 21 |
receptor antagonist | 21 |
cell neoplasia | 21 |
magnetic resonance | 21 |
transgenic pigs | 21 |
phase iii | 21 |
insensitivity syndrome | 21 |
interferon response | 21 |
see section | 21 |
high performance | 21 |
complement system | 21 |
sequence tags | 21 |
airway hyper | 21 |
drug resistant | 21 |
primer pairs | 21 |
high sequence | 21 |
severe combined | 21 |
acid identity | 21 |
united kingdom | 21 |
transduction pathway | 21 |
coronary artery | 21 |
severe sepsis | 21 |
relationships among | 21 |
preclinical studies | 21 |
million years | 21 |
pcr system | 21 |
human papillomavirus | 21 |
mortality rate | 21 |
disease models | 21 |
chinese rufous | 21 |
lung carcinoma | 21 |
irae groups | 21 |
gold standard | 21 |
qpcr analysis | 21 |
disease states | 21 |
factor alpha | 21 |
mrna decay | 21 |
using various | 21 |
rna expression | 21 |
normal tissues | 21 |
cell nuclear | 21 |
important genes | 21 |
principal component | 21 |
recent progress | 21 |
factor binding | 21 |
medical research | 21 |
murine cytomegalovirus | 21 |
major challenge | 21 |
dna molecule | 21 |
profi le | 21 |
ph values | 21 |
gene annotation | 21 |
carbon sources | 21 |
lesser extent | 21 |
upstream open | 21 |
molecular methods | 21 |
functional categories | 21 |
burkitt lymphoma | 21 |
chromatin structure | 21 |
flanking region | 21 |
wide expression | 21 |
transmembrane domain | 21 |
human serum | 21 |
ionizing radiation | 21 |
north american | 21 |
genetic disease | 21 |
gene may | 21 |
airway remodeling | 21 |
vivo delivery | 21 |
normal tissue | 21 |
fungal species | 21 |
rufous horseshoe | 21 |
based denoising | 21 |
published data | 20 |
expression network | 20 |
using either | 20 |
enzyme production | 20 |
conductance regulator | 20 |
previous reports | 20 |
based therapy | 20 |
genes without | 20 |
severe covid | 20 |
false positives | 20 |
results provide | 20 |
controlled trial | 20 |
splicing factor | 20 |
cohort study | 20 |
deduced amino | 20 |
terminal region | 20 |
human clinical | 20 |
target sequence | 20 |
host species | 20 |
probably due | 20 |
strong evidence | 20 |
metabolic network | 20 |
gc content | 20 |
three years | 20 |
normalized expression | 20 |
based analysis | 20 |
component analysis | 20 |
chemically modified | 20 |
higher transfection | 20 |
acid bacteria | 20 |
mortality rates | 20 |
error rate | 20 |
interferon signaling | 20 |
muscular atrophy | 20 |
translational modifications | 20 |
ca influx | 20 |
type iv | 20 |
reservoir host | 20 |
cellular proliferation | 20 |
studies will | 20 |
important factor | 20 |
data collection | 20 |
blood cell | 20 |
insuffi ciency | 20 |
phosphate buffer | 20 |
type mice | 20 |
informed consent | 20 |
type virus | 20 |
bovine coronavirus | 20 |
nondividing cells | 20 |
transmembrane conductance | 20 |
intracellular ca | 20 |
calcium phosphate | 20 |
lipid droplet | 20 |
great deal | 20 |
human beings | 20 |
phylogenetic analyses | 20 |
based methods | 20 |
hormone receptor | 20 |
mechanical ventilation | 20 |
luteinizing hormone | 20 |
infected samples | 20 |
therapeutic strategy | 20 |
fibrosis transmembrane | 20 |
intratumoral injection | 20 |
high molecular | 20 |
increased significantly | 20 |
higher risk | 20 |
protease inhibitors | 20 |
cellular localization | 20 |
coated vesicles | 20 |
batch cultures | 20 |
see table | 20 |
microarray results | 20 |
metabolic pathway | 20 |
several years | 20 |
expression may | 20 |
yellow fever | 20 |
viral loads | 20 |
cellular function | 20 |
cells treated | 20 |
newcastle disease | 20 |
encode proteins | 20 |
gene polymorphisms | 20 |
vitro assays | 20 |
mutual information | 20 |
genetic cause | 20 |
six genes | 20 |
testicular interstitium | 20 |
shake flasks | 20 |
may act | 20 |
envelope glycoprotein | 20 |
tight junction | 20 |
produced using | 20 |
false positive | 20 |
related proteins | 20 |
porcine alveolar | 20 |
encoded proteins | 20 |
potential targets | 20 |
small rnas | 20 |
precursor protein | 20 |
posterior probability | 20 |
like proteins | 20 |
ductuli efferentes | 20 |
large gene | 20 |
colon carcinoma | 20 |
physiological conditions | 20 |
carbonic anhydrase | 20 |
insulin secretion | 20 |
agilent technologies | 20 |
sialic acid | 20 |
antimicrobial agents | 20 |
mouse cst | 20 |
glucose tolerance | 20 |
primary testicular | 20 |
gene order | 20 |
medium composition | 20 |
allow us | 20 |
functional properties | 20 |
retinoic acid | 20 |
culture systems | 20 |
results suggested | 20 |
causing mutations | 20 |
genetic recombination | 20 |
using dna | 20 |
seq datasets | 20 |
nucleotide exchange | 20 |
cre recombinase | 20 |
syndrome patients | 20 |
receptor tyrosine | 20 |
clinical study | 20 |
maximum expression | 20 |
classical swine | 20 |
blood glucose | 20 |
short time | 20 |
binding capacity | 20 |
antigen receptor | 20 |
gene functions | 20 |
two additional | 20 |
mouse embryonic | 20 |
red blood | 20 |
personalized medicine | 20 |
dependent kinase | 20 |
regulatory network | 20 |
therapy vectors | 20 |
specific promoters | 20 |
polymerase ii | 20 |
horizontal evolution | 20 |
multiplex pcr | 20 |
experimental animals | 20 |
million people | 20 |
become increasingly | 20 |
genes encode | 20 |
cystic dysplasia | 20 |
conserved regions | 20 |
protein products | 20 |
alveolar proteinosis | 19 |
pqs kbp | 19 |
widely distributed | 19 |
disease research | 19 |
guinea pigs | 19 |
study shows | 19 |
sequencing reads | 19 |
colony formation | 19 |
specific productivity | 19 |
extracted using | 19 |
surface proteins | 19 |
viruliferous wbph | 19 |
promoter regions | 19 |
health problem | 19 |
certain genes | 19 |
novel approach | 19 |
best reference | 19 |
i gene | 19 |
significant number | 19 |
freely available | 19 |
cell metabolism | 19 |
splice sites | 19 |
disease causing | 19 |
human mast | 19 |
critical care | 19 |
significant enrichment | 19 |
bombyx mori | 19 |
healthy control | 19 |
stably expressing | 19 |
liver disease | 19 |
cultured human | 19 |
genes expression | 19 |
oxidant status | 19 |
data showed | 19 |
movement protein | 19 |
dna strands | 19 |
topological support | 19 |
different strains | 19 |
developed countries | 19 |
log fc | 19 |
complex i | 19 |
cellular level | 19 |
experiments showed | 19 |
cell morphology | 19 |
therapeutic target | 19 |
base composition | 19 |
expression datasets | 19 |
early time | 19 |
darwinian theory | 19 |
gene amplification | 19 |
organic acids | 19 |
glucose levels | 19 |